Abivax ABVX
NASDAQ ABVX
$93.49 +0.90 (+0.97%)
At close: Oct 21, 2026 · 4:00 PM EDT

Abivax (ABVX) Other Non-Current Assets (2022 - 2025)

Updated

Abivax (ABVX) reported Other Non-Current Assets of $727,527 for Q4 2025, down 28.2% from $1.01 million a year earlier.

Analysis

Abivax (ABVX) Other Non-Current Assets (2022 - 2025) Analysis & Trends

At the end of FY2025, Abivax posted Other Non-Current Assets of $706,132, down 31.2% from FY2024.

  • Other Non-Current Assets has a three-year compound annual growth rate of -13.6% (FY2022 to FY2025).
  • By year, Other Non-Current Assets came in at $1.03 million in FY2024 (-59.1%), $2.51 million in FY2023 (+129.6%) and $1.09 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Abivax 6.50 Bn 4.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 734,205.77
Mar 31, 2025 928,692.01
Dec 31, 2024 986,503.21
Jun 30, 2024 1.20 Mn
Dec 31, 2023 2.57 Mn
Dec 31, 2022 1.11 Mn
API Access

Abivax Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABVX&period=max&api_key=YOUR_API_KEY